<DOC>
	<DOCNO>NCT01142622</DOCNO>
	<brief_summary>The purpose study assess intraperitoneal nebulization Ropivacaine 150 mg may prevent use morphine first day laparoscopic ovarian cyst surgery .</brief_summary>
	<brief_title>Intraperitoneal Ropivacaine Nebulization Pain Control After Gynecologic Laparoscopic Surgery</brief_title>
	<detailed_description>In recent study investigator find nebulization Ropivacaine 30 mg gynaecologic laparoscopic surgery significantly reduce postoperative pain postoperative morphine consumption . Ropivacaine effectively administer non-heating nebulizer ( AeronebProÂ® ) . However , almost patient still use morphine surgery . The investigator hypothesize intraperitoneal nebulization Ropivacaine 150 mg may prevent use morphine laparoscopic ovarian cyst surgery .</detailed_description>
	<mesh_term>Ovarian Cysts</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>Females 1865 year old ASA Score IIII Scheduled ovarian cyst laparoscopic surgery Free pain preoperative period Not use analgesic drug surgery Without cognitive impairment mental retardation Written inform consent Emergency/urgency surgery Postoperative admission intensive care unit Cognitive impairment mental retardation Progressive degenerative disease CNS Seizures chronic therapy antiepileptic drug Severe hepatic renal impairment Pregnancy lactation Allergy one specific drug study Acute infection inflammatory chronic disease Alcohol drug addiction</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Ovarian Cysts</keyword>
	<keyword>Nebulization</keyword>
	<keyword>Ropivacaine</keyword>
</DOC>